Bide Pharmatech Co. Ltd. A Cash Flow Quality Index
Bide Pharmatech Co. Ltd. A cash flow quality index. Bide Pharmatech Co. Ltd. A (688073) has a Cash Flow Quality Index of 0.19x as of December 2025. Operating cash flow of CN¥28.32 Million is below net income of CN¥151.74 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Bide Pharmatech Co. Ltd. A (688073) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Bide Pharmatech Co. Ltd. A (2020–2025)
Cash flow quality index of Bide Pharmatech Co. Ltd. A from 2020 to 2025. Historical Cash Flow Quality Index for Bide Pharmatech Co. Ltd. A across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 688073 equity financing ratio to measure how much of total assets are equity-financed.
Bide Pharmatech Co. Ltd. A Cash Flow Quality Index by Year (2020–2025)
Bide Pharmatech Co. Ltd. A cash flow quality index by year from 2020 to 2025. Year-by-year earnings quality comparison for Bide Pharmatech Co. Ltd. A. For the full cash flow conversion analysis, see 688073 cash generation efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | CN¥28.32 Million | CN¥151.74 Million | ▼ -86.2% |
| 2024 | 1.35x | CN¥158.31 Million | CN¥117.43 Million | ▲ +357.4% |
| 2023 | -0.52x | CN¥-57.39 Million | CN¥109.57 Million | ▼ -355.9% |
| 2022 | 0.20x | CN¥29.87 Million | CN¥145.97 Million | ▲ +130.8% |
| 2021 | -0.66x | CN¥-64.88 Million | CN¥97.57 Million | ▼ -1176.4% |
| 2020 | 0.06x | CN¥3.65 Million | CN¥59.00 Million | — |